Adage Capital Management, L.P. 13D/13G Filings for Mereo BioPharma Group plc (MREO)

Adage Capital Management, L.P. 13D and 13G filings for Mereo BioPharma Group plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-12
09:01 am
Purchase
2025-03-3113GMereo BioPharma Group plc
MREO
Adage Capital Management, L.P.8,503,780
1.070%
8,503,780increase
(New Position)
Filing